Public Information for Fiscal Year 2025 Payments

  • *
     Companies that have disclosed information regarding payments for fiscal year 2025 have been removed from the “Disclosed Information for Fiscal Year 2024” section.

Horizontal scrolling is available

Release date (A.D.) Company name Disclosure screen URL
October 14, 2026 Pfizer Japan Inc.

https://www.pfizer.co.jp/pfizer/company/transparency-relationship-measure/payment

October 9, 2026 Asahi Kasei Therapeutics Corporation

https://www.asahi-kasei.co.jp/pharma/csr/#anc-csr-transparency

October 9, 2026 ZERIA PHARMACEUTICAL CO., LTD.

https://www.zeria.co.jp/corporate/compliance/

October 5, 2026 MSD K.K.

https://www.msd.co.jp/about/responsibility/transparency/

October 1, 2026 GlaxoSmithKline K.K.

https://jp.gsk.com/ja-jp/responsibility/ethical-standards/transparency-patient-groups/disclosure-of-financial-support/

October 1, 2026 Meiji Seika Pharma Co., Ltd.

https://www.meiji-seika-pharma.co.jp/corporate/guideline/transparency/

September 30, 2026 Kyowa Kirin Co., Ltd.

https://www.kyowakirin.co.jp/sustainability/management_infrastructure/ethics/index.html#anc-promoting-transparency

September 30, 2026 NIPPON KAYAKU CO., LTD.

https://www.nipponkayaku.co.jp/company/effort/institution.html

September 30, 2026 Eli Lilly Japan K.K.

https://www.lilly.com/jp/policies-reports/transparency-patient

September 30, 2026 TEIJIN PHARMA Limited

https://www.teijin-pharma.co.jp/company/csr/transparency02.html

September 30, 2026 SHIONOGI & CO., LTD.

https://www.shionogi.com/jp/ja/company/compliance/external-activity/kigyou-toumei.html

September 30, 2026 Santen PHARMACEUTICAL CO., LTD.

https://www.santen.com/ja/about/policy/transparency/patientagree

September 29, 2026 TAISHO PHARMACEUTICAL CO., LTD.

https://www.taisho.co.jp/sustainability/data/transparence/

September 25, 2026 Hisamitsu Pharmaceutical Co.,Inc.

https://www.hisamitsu.co.jp/company/guideline/index_p.html

September 18, 2026 Biogen Japan Ltd.

https://www.biogen.co.jp/responsibility/reporting-and-principles/transparency-reporting.html

September 18, 2026 Sumitomo Pharma CO., Ltd.

https://www.sumitomo-pharma.co.jp/sustainability/social/advocacy/transparency/

September 18, 2026 KISSEI PHARMACEUTICAL CO., LTD.

https://www.kissei.co.jp/abouts/conduct/effort/

September 18, 2026 SANWA KAGAKU KENKYUSHO CO., LTD.

https://www.skk-net.com/corporate/csr/transparency/patient.html

September 11, 2026 CHUGAI PHARMACEUTICAL CO., LTD.

https://www.chugai-pharm.co.jp/sustainability/ethics/transparency/index.html

September 10, 2026 Merck Biopharma Co., Ltd.

https://www.merckgroup.com/jp-ja/company/merckbiopharma/transparency_patient/toumeisei_patient2025.html

September 9, 2026 AstraZeneca K.K.

https://www.astrazeneca.co.jp/azkk/responsibility.html

September 1, 2026 Eisai Co., Ltd.

https://www.eisai.co.jp/sustainability/society/disclosure/disclosure2/index.html

August 31, 2026 OTSUKA PHARMACEUTICAL Co., Ltd.

https://www.otsuka.co.jp/company/corporate-governance/patient/

August 31, 2026 EA Pharma Co., Ltd.

https://www.eapharma.co.jp/company/information

August 31, 2026 DAIICHI SANKYO CO., LTD.

https://www.daiichisankyo.co.jp/about_us/info_disclosure/toumeisei_patients/

August 20, 2026 SENJU PHARMACEUTICAL CO., LTD.

https://www.senju.co.jp/about/csr/guideline.html

Share this page

TOP